Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 12 | 17 | 5 | 7 | 31 |
| Cost of Goods | N/A | N/A | 12,598 | N/A | N/A |
| Gross Profit | 12 | 17 | -12,593 | 7 | 31 |
| Operating Expenses | 16,077 | 17,313 | 6,340 | 17,726 | 24,139 |
| Operating Income | -16,065 | -17,296 | -18,335 | -17,719 | -24,108 |
| Interest Expense | 5 | 0 | -367 | 145 | 149 |
| Other Income | 489 | 616 | 47 | 396 | 494 |
| Pre-tax Income | -15,581 | -16,680 | -17,921 | -17,468 | -23,763 |
| Income Tax | N/A | -2 | -36 | -128 | -128 |
| Net Income Continuous | -15,581 | -16,678 | -17,885 | -17,340 | -23,635 |
| Net Income | $-15,581 | $-16,678 | $-17,885 | $-17,340 | $-23,635 |
| EPS Basic Total Ops | -0.16 | -0.17 | -0.22 | -0.22 | -0.30 |
| EPS Basic Continuous Ops | -0.16 | -0.17 | -0.22 | -0.22 | -0.30 |
| EPS Diluted Total Ops | -0.16 | -0.17 | -0.22 | -0.22 | -0.30 |
| EPS Diluted Continuous Ops | -0.16 | -0.17 | -0.22 | -0.22 | -0.30 |
| EBITDA(a) | $-13,875 | $-15,130 | $-15,899 | $-14,851 | $-21,293 |